Moreover, in the sequence of our kinase-directed functional screening, we demonstrated that SK pharmacological inhibitors abrogate IL-7R-mediated signaling, promote mutant IL7R ALL cell death, and delay tumor growth. The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.